Delivery Order SPE2DB22D3301-SPE2DB25FY8EB
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,930.01 and has a performance period through March 2025. The contract is for the supply of Glatiramer 40 mg/mL syringes, a medication used for the treatment of multiple sclerosis. The contract was awarded on an unrestricted basis, with no set-aside designation. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,687.43 Firm Fixed Price delivery order is for the supply of Glatiramer 40 mg/mL syringes, with a completion date of March 4, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,039.05 Firm Fixed Price delivery order is for the supply of 4,560,716,059 units of Glatiramer 40 mg/mL syringes. The contract has an ultimate completion date of April 26, 2023. This award is a task order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,554.09, is for the supply of glatiramer 40 mg/ml syringes. The contract is a firm fixed-price, delivery order type with a completion date of February 11, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GLATIRAMER 40 MG/ML SYRINGE medications. The contract has a completion date of February 16, 2024 and a potential value of $2,832.12. The award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is responsible for delivering the pharmaceutical products to DLA Troop...
- The Defense Logistics Agency awarded a $4,879.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40mg/mL glatiramer syringes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by August 3, 2023 to support DLA's medical supply needs. No subcontractors or set aside designations were indicated. DLA manages the global supply chain for the Department of Defense, ensuring troops have the medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of glatiramer 40 mg/ml syringes, a specialty pharmaceutical product, with a potential value of $2,832.12. It is a firm fixed price delivery order contract with a completion date of February 6, 2024. Amerisourcebergen Drug Corp is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,511.18, is for the delivery of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product Glatiramer 40 mg/mL syringe. The award has a ceiling value of $2,832.12 and an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,832.12 Firm Fixed Price delivery order is for the supply of 4560559530 units of glatiramer 40 mg/ml syringes, with a performance period ending on April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...